As the reduction of mitochondrial mass associated with PINK1 overexpression was higher in MM cells treated with TAK-242/BTZ, we next evaluated if this drug combination activated mitophagy, a key process in the mitochondrial quality control aimed at the removal of dysfunctional mitochondria. The gene discussed is PINK1; the disease is Miyoshi myopathy.